MedPath

PROPOFOL INJECTION

PROPOFOL INJECTION

Approved
DIN Number

02437643

Drug Class

Human

Market Date

Jun 1, 2015

Company
HC

fresenius kabi canada ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02437643
AIG Number0121833001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N01AX10 PROPOFOL
Product Specifications
Dosage FormEmulsion
Route of AdministrationIntravenous
AHFS Classification28:04.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

PROPOFOLActive
Strength: 10 MG / ML
Monograph: PROPOFOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.